Ei Itobayashi

asahi general hospital

H指数:35

被引数:3,684

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions

全球不同地理区域真实世界随访中预测SVR后HCC风险模型的验证

Liver International

IF5.2

2026-06-080

Hidenori Toyoda; Yujin Hoshida; Neehar D. Parikh; Prasun K. Jalal; Federico Piñero; Manuel Mendizabal; Ezequiel Ridruejo; Hugo Cheinquer; Andrea Casadei-Gardini; Mounika Kanneganti; Arndt Weinmann; Markus Peck-Radosavljevic; Jean-Francois Dufour; Pompilia Radu; Gamal Shiha; Riham Soliman; Shiv K. Sarin; Manoj Kumar; Jing-Houng Wang; Pisit Tangkijvanich; Wattana Sukeepaisarnjaroen; Masanori Atsukawa; Haruki Uojima; Akito Nozaki; Makoto Nakamuta; Koichi Takaguchi; Atsushi Hiraoka; Hiroshi Abe; Kentaro Matsuura; Tsunamasa Watanabe; Noritomo Shimada; Kunihiko Tsuji; Toru Ishikawa; Shigeru Mikami; Ei Itobayashi; Philip J. Johnson; Amit G. Singal

Ablation-Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma

在初始使用阿替利珠单抗/贝伐珠单抗控制疾病后，疾病进展时基于消融的挽救策略在肝细胞癌中的应用

Hepatology Research

IF3.4

2026-05-110

PRE

Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

不可切除性肝细胞癌接受阿替利珠单抗联合贝伐珠单抗治疗后出血事件的临床特征、预测因素及抗血栓治疗的影响

Hepatology Research

IF3.4

2026-04-210

PRE

Fujimasa Tada; Atsushi Hiraoka; Hideko Ohama; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-life Practice Experts for HCC (RELPEC) Study Group and hepatocellular carcinoma experts from 48 clinics in Japan (HCC 48) Group

Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab

肝内肿瘤负荷对接受阿替利珠单抗联合贝伐珠单抗治疗的合并肝外转移的肝细胞癌患者预后的影响

Hepatology Research

IF3.4

2026-04-100

PRE

Kazunari Tanaka; Kunihiko Tsuji; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Fujimasa Tada; Hideko Ohama; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-Life Practice Experts for HCC (RELPEC) Study Group and Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group

Changes in the Liver Fibrosis of Patients Who Develop Hepatocellular Carcinoma After a Sustained Virologic Response to Hepatitis C Virus Infection

接受丙型肝炎病毒感染持续病毒学应答后发展为肝细胞癌患者的肝纤维化变化

Journal of Medical Virology

IF4.6

2026-03-060

PRE

The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy

晚期肺癌炎症指数作为接受阿替利珠单抗和贝伐珠单抗治疗不可切除肝癌患者的预后指标

Hepatology Research

IF3.4

2026-03-010

PRE

Lymphocyte–Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab

淋巴细胞-单核细胞比值预测接受度鲁单单抗联合曲美单抗治疗的HCC患者的生存情况

Liver International

IF5.2

2026-02-260

PRE

Tomomitsu Matono; Toshifumi Tada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Takashi Nishimura; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Takanori Matsuura; Yoshihide Ueda; Soo Ki Kim; Hideko Ohama; Fujimasa Tada; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Shinya Fukunishi; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Jumpei Okamura; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the RELPEC Group and HCC 48 Group

Three-Year Long-Term Outcomes in Patients With Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab Treatment in Clinical Practice

临床实践中接受阿替利珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌患者的三年长期预后

Cancer Medicine

IF3.1

2026-02-150

OAAI

Ohama, Hideko; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Tanaka, Hironori; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Matono, Tomomitsu; Kuroda, Hidekatsu; Yata, Yutaka; Nishikawa, Hiroki; Imai, Michitaka; Aoki, Tomoko; Ochi, Hironori; Tamai, Hideyuki; Komatsu, Shohei; Tada, Fujimasa; Nakamura, Shinichiro; Nakamura, Yoshiko; Miyake, Teruki; Yoshida, Osamu; Nouso, Kazuhiro; Morishita, Asahiro; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Tsutsui, Akemi; Nagano, Takuya; Tanaka, Kazunari; Matsuura, Takanori; Koshiyama, Yuichi; Kanayama, Yuki; Noritake, Hidenao; Enomoto, Hirayuki; Matsui, Kosuke; Kaibori, Masaki; Fukumoto, Takumi; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi

Efficacy and Safety of Atezolizumab Plus Bevacizumab Versus Durvalumab Plus Tremelimumab for Unresectable Hepatocellular Carcinoma in Patients With Child-Pugh Class B: A Real-World Study

阿特珠单抗联合贝伐单抗与Durvalumab联合Tremelimumab治疗Child-Pugh B级患者不可切除肝细胞癌的疗效和安全性: 一项真实世界研究

HEPATOLOGY RESEARCH

IF3.4

2026-01-010

PRE

Ohama, Hideko; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Nishimura, Takashi; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Ogawa, Chikara; Hatanaka, Takeshi; Kakizaki, Satoru; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Matono, Tomomitsu; Kuroda, Hidekatsu; Yata, Yutaka; Nishikawa, Hiroki; Tanaka, Hironori; Imai, Michitaka; Aoki, Tomoko; Ochi, Hironori; Tamai, Hideyuki; Komatsu, Shohei; Ueda, Yoshihide; Kim, Soo Ki; Tada, Fujimasa; Nakamura, Shinichiro; Matsuura, Takanori; Nakamura, Yoshiko; Yoshida, Osamu; Nouso, Kazuhiro; Morishita, Asahiro; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Tsutsui, Akemi; Nagano, Takuya; Tanaka, Kazunari; Koshiyama, Yuichi; Kanayama, Yuki; Noritake, Hidenao; Okamura, Jumpei; Enomoto, Hirayuki; Matsui, Kosuke; Kaibori, Masaki; Fukumoto, Takumi; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi

Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early-Stage Viral Disease

日本过去二十年间肝细胞癌治疗结果的演变：早期病毒性疾病的改善

HEPATOLOGY RESEARCH

IF3.4

2025-11-010

Identification of high-risk group for diabetes-associated hepatocellular carcinoma using noninvasive test for liver fibrosis

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

IF1.8

2025-11-010

PRE

Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs

合并脂肪性肝病和慢性乙型肝炎对核苷（酸）类似物治疗反应的影响

JOURNAL OF VIRAL HEPATITIS

IF2.3

2025-10-010

PRE

Chau, Angela; Li, Jie; Jun, Dae Won; Hsu, Yao-Chun; Toyoda, Hidenori; Yeh, Ming-Lun; Watanabe, Tsunamasa; Honda, Takashi; Trinh, Huy; Nozaki, Akito; Uojima, Haruki; Ishikawa, Toru; Huang, Daniel Q.; Vutien, Philip; Marciano, Sebastian; Abe, Hiroshi; Atsukawa, Masanori; Enomoto, Masaru; Takahashi, Hirokazu; Tsuji, Kunihiko; Takaguchi, Koichi; Itobayashi, Ei; Huang, Rui; Tsai, Pei-Chien; Dai, Chia-Yen; Huang, Jee-Fu; Huang, Chung-Feng; Yoon, Eileen; Kim, Sung Eun; Ahn, Sang Bong; Kim, Gi-Ae; Jung, Jang Han; Jeong, Soung Won; Oh, Hyunwoo; Hsiao, Tiffany; Maeda, Mayumi; Tseng, Cheng-Hao; Yasuda, Satoshi; Ishigami, Masatoshi; Chuma, Makoto; Ito, Takanori; Kawashima, Keigo; Liu, Joanne Kimiko; Itokawa, Norio; Kozuka, Ritsuzo; Inoue, Kaori; Senoh, Tomonori; Chuang, Wan-Long; Gadano, Adrian; Tanaka, Yasuhito; Lim, Seng Gee; Wu, Chao; Cheung, Ramsey; Yu, Ming-Lung; Nguyen, Mindie H.

Clinical Utility of a Prognostic Scoring System Based on LDH and CRP in HCC Patients Receiving Atezolizumab Plus Bevacizumab

基于LDH和CRP的预后评分系统在应用阿替利珠单抗联合贝伐珠单抗治疗的HCC患者中的临床应用价值

LIVER INTERNATIONAL

IF5.2

2025-09-190

PRE

Tanaka, Kazunari; Tsuji, Kunihiko; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Ishikawa, Toru; Tajiri, Kazuto; Ohama, Hideko; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Matono, Tomomitsu; Kuroda, Hidekatsu; Yata, Yutaka; Nishikawa, Hiroki; Imai, Michitaka; Aoki, Tomoko; Ochi, Hironori; Kanayama, Yuki; Tada, Fujimasa; Nakamura, Shinichiro; Nouso, Kazuhiro; Morishita, Asahiro; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Tsutsui, Akemi; Tanaka, Hironori; Noritake, Hidenao; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi

Efficacy and Safety of Durvalumab Plus Tremelimumab in Hepatocellular Carcinoma Patients With Portal Vein Thrombosis and High Tumor Burden: A Multicenter Retrospective Analysis

度鲁特玛联合特瑞普利单抗在合并门静脉血栓和高肿瘤负荷的肝细胞癌患者中的有效性与安全性：一项多中心回顾性分析

Hepatology Research

IF3.4

2025-09-060

PRE

Hatanaka, Takeshi; Yata, Yutaka; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Kakizaki, Satoru; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Koshiyama, Yuichi; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Kawata, Kazuhito; Kosaka, Hisashi; Matsui, Kosuke; Naganuma, Atsushi; Tanaka, Hironori; Ohama, Hideko; Kuroda, Hidekatsu; Matono, Tomomitsu; Aoki, Tomoko; Ochi, Hironori; Imai, Michitaka; Nakamura, Shinichiro; Komatsu, Shohei; Tamai, Hideyuki; Okamura, Jumpei; Kanayama, Yuki; Tanaka, Kazunari; Tada, Fujimasa; Yoshida, Osamu; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Matsuura, Takanori; Noritake, Hidenao; Enomoto, Hirayuki; Kaibori, Masaki; Fukumoto, Takumi; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi

Carbon-ion radiotherapy achieves outcomes equivalent to surgical resection for hepatocellular carcinoma

碳离子放射治疗对于肝细胞癌的治疗效果与手术切除相当。

Hepatology Communications

IF4.6

2025-08-290

OAAI

Potential role of Geriatric Nutritional Risk Index as a risk factor for immune-mediated adverse events during durvalumab plus tremelimumab therapy in unresectable hepatocellular carcinoma

格瑞特营养风险指数作为不可切除肝癌患者接受度伐利尤单抗联合特瑞普利单抗治疗期间免疫介导不良反应的风险因素的潜在作用

Journal of Gastroenterology

IF5.5

2025-08-200

PRE

Hideko Ohama; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Fujimasa Tada; Shinichiro Nakamura; Yoshiko Nakamura; Teruki Miyake; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Takanori Matsuura; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada

Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort study

代谢功能障碍对核苷(酸)类似物治疗慢性乙型肝炎反应的影响：一项回顾性多中心REAL-B队列研究

eClinicalMedicine

IF10

2025-08-110

PREAI

Rui Huang; Dae Won Jun; Hidenori Toyoda; Yao-Chun Hsu; Huy Trinh; Akito Nozaki; Toru Ishikawa; Tsunamasa Watanabe; Haruki Uojima; Daniel Q. Huang; Takashi Honda; Yasuhito Tanaka; Philip Vutien; Sebastián Marciano; Hiroshi Abe; Masaru Enomoto; Masanori Atsukawa; Hirokazu Takahashi; Kunihiko Tsuji; Ei Itobayashi; Koichi Takaguchi; Pei-Chien Tsai; Chia-Yen Dai; Jee-Fu Huang; Chung-Feng Huang; Ming-Lun Yeh; Eileen Yoon; Sung Eun Kim; Sang Bong Ahn; Gi-Ae Kim; Jang Han Jung; Soung Won Jeong; Hyunwoo Oh; Cheng-Hao Tseng; Masatoshi Ishigami; Angela Chau; Tiffany Hsiao; Mayumi Maeda; Satoshi Yasuda; Makoto Chuma; Takanori Ito; Keigo Kawashima; Joanne Kimiko Liu; Adrian Gadano; Ritsuzo Kozuka; Norio Itokawa; Kaori Inoue; Tomonori Senoh; Jie Li; Wan-Long Chuang; Ramsey Cheung; Chao Wu; Ming-Lung Yu; Mindie H. Nguyen

Safety and Efficacy of Durvalumab Plus Tremelimumab in Older Individuals With Unresectable Hepatocellular Carcinoma: A Multicenter Analysis

达鲁瓦鲁单抗联合特雷美鲁单抗在不可切除肝细胞癌老年患者中的安全性与有效性：一项多中心分析

Hepatology Research

IF3.4

2025-08-060

PRE

Tomomitsu Matono; Toshifumi Tada; Takashi Kumada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Hiroki Nishikawa; Kazunari Tanaka; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Yuichi Koshiyama; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Hidenao Noritake; Hideko Ohama; Fujimasa Tada; Kazuhiro Nouso; Asahiro Morishita; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Tomomi Okubo; Taeang Arai; Takashi Nishimura; Michitaka Imai; Hisashi Kosaka; Atsushi Naganuma; Tomoko Aoki; Hidekatsu Kuroda; Yutaka Yata; Hideyuki Tamai; Takanori Matsuura; Shohei Komatsu; Yoshihide Ueda; Yoshiko Nakamura; Osamu Yoshida; Kosuke Matsui; Shinichiro Nakamura; Hirayuki Enomoto; Masaki Kaibori; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; the Real-life Practice Experts for HCC (RELPEC) Study Group and the Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group

Comparison of Surgical Resection and Radiofrequency Ablation for Early-Stage HCC Patients With Child-Pugh Class B

早期肝细胞癌Child-Pugh B级患者手术切除与射频消融的比较

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2025-05-270

PRE

Impact of time-of-day atezolizumab plus bevacizumab combination therapy infusion for unresectable hepatocellular carcinoma: A retrospective multicenter study

HEPATOLOGY RESEARCH

IF3.4

2025-02-090

PRE

Naganuma, Atsushi; Kakizaki, Satoru; Hatanaka, Takeshi; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Koshiyama, Yuichi; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Kawata, Kazuhito; Kosaka, Hisashi; Matsui, Kosuke; Yata, Yutaka; Tanaka, Hironori; Ohama, Hideko; Kuroda, Hidekatsu; Matono, Tomomitsu; Aoki, Tomoko; Ochi, Hironori; Imai, Michitaka; Nakamura, Shinichiro; Kanayama, Yuki; Tanaka, Kazunari; Tada, Fujimasa; Yoshida, Osamu; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Enomoto, Hirayuki; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi

Ei Itobayashi

个人简介

教育背景

工作经历

荣誉奖项

研究方向